Promising early results for a new treatment in head and neck cancer
Victoria Villaflor, MD shared promising early results at ASCO 2026 for a new treatment approach in head and neck cancer.
-
1
Dr. Victoria Villaflor presented early results for a new treatment approach in head and neck cancer at ASCO 2026.
-
2
The study focused on a targeted therapy for patients with tumors expressing a specific protein marker.
-
3
This protein marker is often associated with less favorable outcomes in head and neck cancer.
-
4
The treatment showed positive responses in patients who had undergone multiple prior treatments.
-
5
Patients with a history of struggling to find effective options benefited from this new approach.
